YU53193A - Vakcina za virus hepatitisa a - Google Patents

Vakcina za virus hepatitisa a

Info

Publication number
YU53193A
YU53193A YU53193A YU53193A YU53193A YU 53193 A YU53193 A YU 53193A YU 53193 A YU53193 A YU 53193A YU 53193 A YU53193 A YU 53193A YU 53193 A YU53193 A YU 53193A
Authority
YU
Yugoslavia
Prior art keywords
hav
hepatitis
virus vaccine
yield
hepatitis virus
Prior art date
Application number
YU53193A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
A.R. Aboud
G.J. Aunins
C.B. Buckland
A.P. Dephillips
J.A. Hagen
P.J. Hennessey
B. Junker
A.J. Lewis
N.C. Oliver
J.C. Orella
D.R. Sitrin
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of YU53193A publication Critical patent/YU53193A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02Recovery or purification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
YU53193A 1992-08-07 1993-08-05 Vakcina za virus hepatitisa a YU53193A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92687392A 1992-08-07 1992-08-07

Publications (1)

Publication Number Publication Date
YU53193A true YU53193A (sh) 1996-10-09

Family

ID=25453825

Family Applications (1)

Application Number Title Priority Date Filing Date
YU53193A YU53193A (sh) 1992-08-07 1993-08-05 Vakcina za virus hepatitisa a

Country Status (6)

Country Link
KR (1) KR950703054A (enrdf_load_stackoverflow)
HR (1) HRP931103A2 (enrdf_load_stackoverflow)
IL (1) IL106609A0 (enrdf_load_stackoverflow)
MY (1) MY137408A (enrdf_load_stackoverflow)
TW (1) TW259708B (enrdf_load_stackoverflow)
YU (1) YU53193A (enrdf_load_stackoverflow)

Also Published As

Publication number Publication date
TW259708B (enrdf_load_stackoverflow) 1995-10-11
KR950703054A (ko) 1995-08-23
IL106609A0 (en) 1993-12-08
MY137408A (en) 2009-01-30
HRP931103A2 (hr) 1995-02-28

Similar Documents

Publication Publication Date Title
MX9304803A (es) Vacuna de virus de hepatitis a.
DE69022290D1 (de) Lebende Impfstoffe.
LV10203A (lv) Panemiens inficesanas ar AIDS noteiksanai olbaltumvielu kompozicija test-komplekts
CA2098105A1 (fr) Oligoside derive d'un polyoside antigenique issu d'un agent pathogene
PT625053E (pt) Vacina a base de urease contra a infeccao por helicobacter
HU9201258D0 (en) Process for the production of medical preparations for treating hiv infections and of their active agents
ES8404186A1 (es) "un procedimiento para obtener al menos un polipeptido que presenta la antigenicidad de los antigenos e del virus de la hepatitis b".
US5276142A (en) Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis
EP0198299A3 (en) A process for preparing hepatitis b surface antigen containing particles in novel forms which are highly immunogenic
YU53193A (sh) Vakcina za virus hepatitisa a
NO872919L (no) Fremstilling av pertussis-toksin ved dyrkning av bodella pertussis.
ATE29387T1 (de) Aus hefepilzen jeder art erhaltene stoffwechsel aktivierende praeparationen.
AU601415B2 (en) A process for the purification, solubilization and/or detoxification of protein antigens of bacteria of the bordetella genus using a carbonate buffer and an acellular anti-whooping cough vaccine
US3769415A (en) Method of preparing a killed vaccine for oral use
EP0090660A3 (en) Neisseria gonorrhoeae vaccine
Fantes Interferons: purification and physicochemical aspects
FR2736064B1 (fr) Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella
FR2589063B1 (fr) Procede de culture de babesia canis, application a la preparation d'antigenes et de vaccins, et antigenes et vaccins contre la piroplasmose
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
US3399113A (en) Propagation of ich virus in swine-lung tissue culture
DE59610052D1 (de) Verfahren zur Inaktivierung von Carboxypeptidase Y in hirudinhaltigen Kulturbrühen
Sen et al. Development of an effective vaccine against foot-and-mouth disease with partially purified and concentrated virus antigen
BE837603A (fr) Vaccin contre la grippe contenant de la neuraminidase purifiee comme antigene et procede pour l'administrer
SU1835658A1 (ru) Способ получения авирулентного иммуносорбента для выявления постинфекционных антител при ретроспективной диагностике ящура
FR2674536B1 (fr) Procede d'inactivation de virus et composition pharmaceutique pour l'inactivation de virus.